Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,099,736
+$837,367 QoQ
Shares Held
20,266
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#1,297
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. ABBV ranks #1 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,099,736 | 20,266 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,262,369 | 19,598 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $4,354,105 | 19,056 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,221,205 | 18,231 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $3,289,743 | 17,723 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,687,971 | 17,602 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,130,540 | 17,617 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,769,498 | 19,088 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,221,488 | 18,782 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,195,855 | 17,550 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,608,941 | 23,288 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $3,352,508 | 22,491 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $3,013,101 | 22,364 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,892,293 | 24,423 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,871,044 | 23,953 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,314,450 | 24,696 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,772,330 | 24,630 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $4,356,706 | 26,875 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,855,108 | 28,472 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,285,720 | 30,460 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,434,168 | 30,488 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,445,724 | 31,840 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,948,584 | 36,851 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,426,082 | 39,115 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,940,061 | 40,131 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,567,685 | 20,576 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||